The Changing Course: Reversing Direct Oral Anticoagulants in the Emergency Department that will be hosted by the Maryland ACEP Chapter will now be held on Thursday, March 18th in conjunction with the Maryland ACEP Chapter Educational Conference & Annual Meeting. By combining these two events, you will be able to get 7-seven hours of CME. Registration and other information will be posted as it becomes available.
The development of direct oral anticoagulants (DOACs) has advanced the therapeutic landscape for the management of thromboembolic events. Specific agents that rapidly reverse the effects of DOACs are now available and offer safe and effective options for patients who experience an emergency DOAC-associated bleeding event.
This ACEP Chapter Educational Lecture Series will offer:
• Clinical pearls for the assessment of bleeding severity in patients receiving DOACs
• Expert-guided insights to rapid reversal of urgent DOAC associated bleeding
• Clinical decision support tools to optimize outcomes in patients requiring reversal of DOACs
• Emergency medicine physicians and physician assistants
Upon completion of this activity, learners should be better able to:
• IDENTIFY the signs and symptoms of severe bleeding in patients receiving DOAC therapy
• ASSESS anticoagulant activity in individuals who present with DOAC associated bleeding or who require emergency surgery
• DETERMINE appropriate reversal agents based on the type of anticoagulant, dose, timing of last dose, and indication
• IMPLEMENT local protocols for evaluating patients and managing DOAC-associated bleeding
Accreditation and Credit Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Emergency Physicians, Spire Learning, and the Maryland Chapter of the American College of Emergency Physicians. The American College of Emergency Physicians is accredited by the ACCME to provide continuing medical education for physicians.
The American College of Emergency Physicians designates this live activity for a maximum of 1.0 AMA
PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Approved by the American College of Emergency Physicians for 1.0 hour(s) of ACEP Category I credit.
There is no fee to participate in this activity. This activity is supported by an educational grant from Portola Pharmaceuticals, Inc.